Search For "serum"
Covishield will get EMA approval in a month, says Adar Poonawala at Indian
Updated : 4 years, 8 months ago IST
New Delhi [India], June 30 (ANI): Serum Institute of India is confident of receiving approval from the European Medicines Agency (EMA) for its COVID-19 vaccine Covishield in a month, the company's CEO Adar Poonawalla informed on Wednesday.
Read More
No ban on Covishield, EMA can't start any procedure without request from m
Updated : 4 years, 8 months ago IST
New Delhi [India], June 29 (ANI): EU Ambassador to India Ugo Astuto has clarified that there is no ban in the European Union on Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University.
Read More
EU travel issues faced by Indians given Covishield taken up at 'highest le
Updated : 4 years, 8 months ago IST
Pune (Maharashtra) [India], June 28 (ANI): Adar Poonawalla, Chief Executive Officer (CEO) and owner of the Serum Institute of India (SII) on Monday assured Indians who have taken Covishield doses and are now facing issues while travelling to European Union countries that the matter had been
Read More
Novavax's COVID-19 vaccine 'Covavax' to launch in India by September: Sour
Updated : 4 years, 9 months ago IST
New Delhi [India], June 17 (ANI): The Serum Institute of India (SII) hopes to introduce US firm Novavax's Indian version of the COVID-19 vaccine - 'Covavax' by September this year and start trials on children from July.
Read More
Covid-19: No newborn calf serum in final Covaxin product, says Health mini
Updated : 4 years, 9 months ago IST
New Delhi [India], June 16 (ANI): The Union Health Ministry on Wednesday said that newborn calf serum is not an ingredient of the final Covaxin vaccine by Bharat Biotech.
Read More
Novavax's vaccine, also produced by SII, found 90 pc effective against COV
Updated : 4 years, 9 months ago IST
New Delhi [India], June 14 (ANI): US Biotechnology company Novavax on Monday announced that its Covid-19 vaccine provides 100 per cent protection against moderate and severe symptoms of the disease and 90.4 per cent efficacy overall in phase 3 trials.
Read More
No changes as of now in gap between Covishield doses, say govt sources
Updated : 4 years, 9 months ago IST
New Delhi [India], June 12 (ANI): Amid calls to reduce the gap between two doses of Serum Institute of India's COVID-19 vaccine Covishield based on the new findings by Public Health England, the Central government will not take the decision to change the dosage interval immediately, said
Read More
Centre threatened Adar Poonawalla for promising 1.5 cr vaccine doses to Ma
Updated : 4 years, 9 months ago IST
Ahmednagar (Maharashtra) [India], June 7 (ANI): Maharashtra Minister and Nationalist Congress Party (NCP) leader, Hasan Mushrif on Monday alleged that Serum Insititute of India's Chief Adar Poonawalla was forced to flee the country as he was receiving threats from the Centre for promising
Read More
Adar Poonawalla thanks Biden, Jaishankar as US lifts Defence Production Ac
Updated : 4 years, 9 months ago IST
New Delhi [India], June 4 (ANI): After US lifted embargo on the raw materials required to produce COVID-19 vaccine, Serum Institute of India (SII) CEO Adar Poonawalla credited US President Joe Biden and Externals Affairs Minister S Jaishankar for the "policy change", stating that this will h
Read More
DCGI grants SII permission to manufacture Sputnik V for specific regulator
Updated : 4 years, 9 months ago IST
New Delhi [India], June 4 (ANI): The Drug Controller General of India (DCGI) on Friday granted the approval to the Serum Institute of India (SII) for the initial manufacture of the Russian COVID-19 vaccine Sputnik V for testing, examination, and analysis purposes with certain conditions at i
Read More
SII seeks DCGI's permission for test license to manufacture Sputnik V COVI
Updated : 4 years, 9 months ago IST
New Delhi [India], June 3 (ANI): Indian vaccine manufacturing company Serum Institute of India (SII) has sought permission from the Drug Controller General of India (DCGI) for the production of the Russian vaccine Sputnik V in India.
Read More
After Pfizer, Serum Institute seeks indemnity over COVID-19 vaccine: Sourc
Updated : 4 years, 9 months ago IST
New Delhi [India], June 3 (ANI): Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their COVID-19 jabs in India, the Serum Institute of India (SII) has also sought protection against liabilities, sources said on Thursday.
Read More